Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian heart Rhythm Society

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search NSF DL


Advanced Search

We Want your Feedback

Browse

My Account

Quick Links